The clinical and epidemiological characteristics of patients with potentially HPV-related head and neck cancers: results of a sampling study
- Authors: Belyakova E.N.1, Sekacheva M.I.1, Lopukhov P.D.1, Briko N.I.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- Issue: Vol 11, No 2 (2021)
- Pages: 63-68
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/287736
- DOI: https://doi.org/10.18565/epidem.2021.11.2.63-8
- ID: 287736
Cite item
Abstract
Full Text
About the authors
Ekaterina N. Belyakova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: beliackova.caterina@yandex.ru
Postgraduate Student
Marina I. Sekacheva
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: sekacheva_m_i@staff.sechenov.ru
MD, Director, Institute of Cluster Oncology, Head, «OncoTarget» Personalized Oncology Center
Platon D. Lopukhov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: pl2211@yandex.ru
Cand. Med. Sci., Associate Professor, Department of Epidemiology and Evidence-Based Medicine
Nikolay I. Briko
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: nbrico@mail.ru
MD, Academician of the Russian Academy of Sciences, Honored Scientist of the Russian Federation, Director; Head, Department of Epidemiology and Evidence-Based Medicine
References
- Kofler B., Laban S., Busch C.J., Lorincz B., Knecht R. New treatment strategies for HPV-positive head and neck cancer. Eur. Arch. Otorhinolaryngol. 2014; 271(7): 1861-7. doi: 10.1007/s00405-013-2603-0
- Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L. et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000; 92(9): 709-20. doi: 10.1093/ jnci/92.9.709
- Pimenoff V.N., de Oliveira C.M., Bravo I.G. Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16. Mol. Biol. Evol. 2017; 34(1): 4-19. doi: 10.1093/molbev/msw214
- De Villiers E.-M., Fauquet C., Broker T. R., Bernard H.-U., zur Hausen H. Classification of papillomaviruses. Virology 2004; 324(1): 17-27. doi: 10.1016/j.virol.2004.03.033
- de Martel C., Georges D., Bray F., Ferlay J., Clifford G.M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health. 2020; 8(2): e180-90. doi: 10.1016/S2214-109X(19)30488-7
- Mena M., Frias-Gomez J., Taberna M., Quir6s B., Marquez S., Clavero O. et al. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe. Sci. Rep. 2020; 10(1): 13219. doi: 10.103 8/s41598 -020 -70118-7
- Белякова Е.Н., Брико Н.И., Лопухов П.Д. Характеристика заболеваемости раком головы и шеи, потенциально ассоциированным с вирусом папилломы человека, в России в 2007-2018 гг. Профилактическая медицина 2021; 24(2): 30-6. https://doi.org/ 10.17116/profmed20212402130
- Castellsagu6 X., Alemany L., Quer M. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J. Natl. Cancer Inst. 2016; 108(6): djv403. doi: 10.1093/jnci/djv403
- Rettig E.M., Zaidi M., Faraji F., Eisele D.W., El Asmar M., Fung N., et al. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: Analysis of the national cancer database. Oral. Oncol. 2018; 83: 147-53. doi: 10.1016/j. oraloncology.2018.06.013
- Chaturvedi A.K., Anderson W.F., Lortet-Tieulent J., Curado M.P., Ferlay J., Franceschi S. et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 2013; 31: 4550-9. doi: 10.1200/JCQ.2013.50.3870
- WHO/IVB Database, as at June 2020 Map production: Countries with HPV vaccine in the national immunization programme. https://www.who.int/immunization/monitoring_surveillance/VaccineIntroStatus.pptx
- Grant A., Hansl B. Russia economic report: the dawn of a new economic era? Russia economic report. Washington, DC: World Bank Group, 2015.
- Onerci Celebi O., Sener E., Hosal S., Cengiz M., Gullu I., & Guler Tezel G. Human papillomavirus infection in patients with laryngeal carcinoma. BMC Cancer 2018; 18(1). doi: 10.1186/s12885-018-4890-8
- Anantharaman D., Abedi-Ardekani B., Beachler D.C., Gheit T., Olshan A. F., Wisniewski K. et al. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int. J. Cancer 2017; 140(9): 1968-75. doi:10.1002/ ijc.30608
- Giuliano A.R., Nyitray A.G., Kreimer A.R., Pierce Campbell C.M., Goodman M.T., Sudenga S.L. et al. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int. J. Cancer. 2015; 136: 2752-60. doi: 10.1002/ ijc.29082
- Ho G.Y., Studentsov Y., Hall C.B., Bierman R., Beardsley L., Lempa M., Burk R.D.: Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J. Infect. Dis. 2002; 186: 737-42. doi: 10.1086/342972
- Kingma D.W., Allen R.A., Moore W., Caughron S.K., Melby M., Gillies E.M. et al. HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Anticancer Res. 2010; 30(12): 5099-104.
- Anil K., Chaturvedi E., Engels A., Hernandez B.Y., Xiao W., Kim E., et al. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. J. Clin. Oncol. 2011; 29(32): 4294-301. doi: 10.1200/JCO.2011.36.4596
- Fakhry C., Westra W.H., Wang S.J., Zante A., Zhang Y., Rettig E. et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer 2017; 123(9): 1566-75. doi: 10.1002/cncr.30353
- Meng H., Miao S., Chen K., Li H., Yao G., Geng J. et al. Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China. BioMed Res. Int. 2018: 1-8. doi: 10.1155/2018/9594568
- Tsai S. C.-S., Huang J.-Y., Lin C., Liaw Y.P., Lin F.C. The association between human papillomavirus infection and head and neck cancer. Medicine (Baltimore). 2019; 98(7): e14436. doi: 10.1097/md. 0000000000014436
- Fakhry C., Westra W. H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved Survival of Patients with Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial. JNCI 2008; 100(4): 261-9. doi: 10.1093/jnci/djn011